Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease | Zendy

John A. Bittl | Zendy; Yulei He | Zendy; Alice K. Jacobs | Zendy; Clyde W. Yancy | Zendy; SharonLise T. Normand | Zendy

Open Access

Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease

Author(s) -

John A. Bittl,

Yulei He,

Alice K. Jacobs,

Clyde W. Yancy,

SharonLise T. Normand

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.112.000646

Subject(s) - medicine , left main coronary artery disease , percutaneous coronary intervention , cardiology , coronary artery disease , coronary disease , disease , left coronary artery , myocardial infarction , coronary heart disease

Several randomized clinical trials support the use of coronary artery bypass grafting (CABG) for patients with unprotected left main coronary artery disease. Studies suggesting the equivalence of percutaneous coronary intervention (PCI) with CABG for this indication indirectly support the 2011 American College of Cardiology Foundation/American Heart Association Class IIa recommendation for PCI to improve survival in patients with unprotected left main coronary artery disease. We tested whether bayesian approaches uphold the new recommendation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research